346 related articles for article (PubMed ID: 20861488)
1. Molecular and clinical characterization of albinism in a large cohort of Italian patients.
Gargiulo A; Testa F; Rossi S; Di Iorio V; Fecarotta S; de Berardinis T; Iovine A; Magli A; Signorini S; Fazzi E; Galantuomo MS; Fossarello M; Montefusco S; Ciccodicola A; Neri A; Macaluso C; Simonelli F; Surace EM
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1281-9. PubMed ID: 20861488
[TBL] [Abstract][Full Text] [Related]
2. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
3. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
4. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
Hutton SM; Spritz RA
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation and molecular screening of a large consecutive series of albino patients.
Mauri L; Manfredini E; Del Longo A; Veniani E; Scarcello M; Terrana R; Radaelli AE; Calò D; Mingoia G; Rossetti A; Marsico G; Mazza M; Gesu GP; Cristina Patrosso M; Penco S; Piozzi E; Primignani P
J Hum Genet; 2017 Feb; 62(2):277-290. PubMed ID: 27734839
[TBL] [Abstract][Full Text] [Related]
9. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.
Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR
Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
12. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
Kessel L; Kjer B; Lei U; Duno M; Grønskov K
Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of Korean patients with oculocutaneous albinism.
Park SH; Chae H; Kim Y; Kim M
Jpn J Ophthalmol; 2012 Jan; 56(1):98-103. PubMed ID: 22042571
[TBL] [Abstract][Full Text] [Related]
15. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
17. Oculocutaneous albinism (OCA) in Japanese patients: five novel mutations.
Okamura K; Yoshizawa J; Abe Y; Hanaoka K; Higashi N; Togawa Y; Nakagawa S; Kambe N; Funasaka Y; Ohko K; Hozumi Y; Suzuki T
J Dermatol Sci; 2014 May; 74(2):173-4. PubMed ID: 24461674
[No Abstract] [Full Text] [Related]
18. SLC45A2 variations in Indian oculocutaneous albinism patients.
Sengupta M; Chaki M; Arti N; Ray K
Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386
[TBL] [Abstract][Full Text] [Related]
19. A Japanese Family With Autosomal Dominant Oculocutaneous Albinism Type 4.
Oki R; Yamada K; Nakano S; Kimoto K; Yamamoto K; Kondo H; Kubota T
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1008-1016. PubMed ID: 28192564
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
